Virtanen, Verneri http://orcid.org/0000-0001-7111-3297
Paunu, Kreetta
Kukkula, Antti
Niva, Saana http://orcid.org/0009-0009-8256-1648
Junila, Ylva
Toriseva, Mervi
Jokilehto, Terhi
Mäkelä, Sari
Huhtaniemi, Riikka
Poutanen, Matti
Paatero, Ilkka
Sundvall, Maria http://orcid.org/0000-0002-0494-2965
Funding for this research was provided by:
Academy of Finland
Suomen Lääketieteen Säätiö
Syöpäsäätiö
Suomen Kulttuurirahasto
Article History
Received: 22 December 2022
Revised: 18 July 2023
Accepted: 25 July 2023
First Online: 12 August 2023
Competing interests
: VV has received support to participate in educational events and conferences from Janssen. MS has received support to participate in educational events and conferences from Astellas, Amgen, Bayer, Novartis, BMS, Pierre Fabre, Lilly, and Roche; and received consultant fees from MSD, BMS, Roche, and Ipsen. KP, AK, SN, YJ, MT, TJ, and IP declare no competing financial interests.